53rd Annual Meeting of the European Association for the study of Diabetes EASD

Relateret indhold

• Publikationer

• Metformin potentiates bile acid-induced GLP-1 secretion in patients with type 2 diabetes

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Baseline characteristics in PRIORITY study: Proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in type 2 diabetes

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Semaglutide provides sustained reductions in body weight over 2 years in subjects with type 2 diabetes (SUSTAIN 6)

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• The role of glucagon in gastrointestinal-mediated glucose-disposal and incretin effect in patients with type 2 diabetes and normal glucose tolerant individuals

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• The effect of liraglutide on bone turnover during exercise training in patients with type 2 diabetes

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• The effects of GIP/GLP-1 receptor co-activation on appetite and food intake in overweight/obese subjects

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• IDegLira improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, mortality and deterioration in kidney function in patients with type 2 diabetes

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Insulin degludec/liraglutide (IDegLira) is efficacious and safe in patients with type 2 diabetes with normal, mild or moderate renal impairment: analyses from phase 3 trials

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Total events of hospitalisation for heart failure in new users of SGLT-2 inhibitors: real world data from 5 countries and more than 298,000 patients: the CVD-REAL study

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Long term sickness absence and diabetes: a Danish register-based longitudinal study with up to 17 years of followup

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Changes in metabolites in response to metformin during the 18-month Copenhagen Insulin and Metformin Therapy (CIMT) Trial

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• The effect of liraglutide on oxidative nucleic acid modifications in women with prior gestational diabetes

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Reduced sublingual endothelial glycocalyx in type 1 diabetic patients with diabetic nephropathy

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

• Is double-blinding achievable in a placebo-controlled trial with the glucagon-like-peptide-1 receptor agonist liraglutide?

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Prevalence of diabetic neuropathy in adolescents with type 1 diabetes and the association to insulin pump therapy

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Family dialogue tools: how can healthcare professionals facilitate mutual involvement in families dealing with type 2 diabetes

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Estimates of pre-diabetes and undiagnosed diabetes in Denmark

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Bone turnover in women with prior gestational diabetes after 52 week's treatment with liraglutide

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Risk of heart failure in intensively treated patients with type 2 diabetes and microalbuminuria: 21 years follow-up in the multifactorial Steno-2 intervention

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Relative contributions of fasting and postprandial glycaemia to HbA1c among persons with normal, pre-diabetes and diabetes HbA1c levels

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Incidence and predictors of recurrent and new diabetic foot ulcers

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Increased liver fat content in totally pancreatectomised patients

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Non-disclosure of type 2 diabetes at work among Danish employees

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Converting to IDegLira is efficacious regardless of pre-trial insulin dose in patients with type 2 diabetes uncontrolled on insulin glargine U100

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Predicting total burden of diabetes in Denmark till 2030

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• The glucagon-like peptide-1 receptor agonist lixisenatide reduces postprandial glucose excursions in totally pancreatectomised patients

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Cluster analyses of patients with dysregulated type 2 diabetes based on routine clinical markers reveal cluster-specific prevalence of diabetes complications

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Role of the gut in glucose-induced suppression of bone resorption in patients with non-alcoholic fatty liver disease and/or type 2 diabetes

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• GDF-15 and FGF-23 are associated with mortality in type 2 diabetic patients with microalbuminuria

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Autonomic regulation may modify the weight reducing effect of liraglutide in overweight patients with type 1 diabetes

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Mortality rate in patients with type 1 diabetes with multiple micravascular complications

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Aktiviteter

• Incidence and predictors of recurrent and new diabetic foot ulcers,

  Aktivitet: Tale eller præsentation › Foredrag og mundtlige bidrag